✨ Abstract Submissions Are Now Open!
15th Global Summit on Diabetes & Endocrine Disorders (2026)
🗓️ July 22–23, 2026 |
📍 Tokyo, Japan & Virtual
🔗Submit your abstract now:
diabetes.inovineconferences.com/submit-abstr...

#artificialpancreas
#diabetestechnology
#digitaldiabetescare
#endocrinesummit

Hybrid closed‑loop technology outperforms traditional insulin pump therapy, Leicester analysis shows — Leicester Diabetes Centre A study by Leicester experts in diabetes has confirmed that hybrid closed-loop systems outperform sensor-augmented pumps in type 1 diabetes management.

A study by LDC experts in diabetes has confirmed that hybrid closed-loop systems outperform sensor-augmented pumps in #type1diabetes management.

Read the full article: www.leicesterdiabetescentre.org.uk/news-blog/hy...

#HCL #DiabetesTechnology

Harrogate runner: 'My artificial pancreas makes running easier' - BBC News Jonty Brown, from Harrogate, says new technology helps keep him running while managing his diabetes.

Great story - hoping #closedloop insulin systems can be rolled out more widely and quickly! #T1D #diabetestechnology #running #ultramarathons
www.bbc.com/news/article...

⏰Application deadline extended! Don’t miss your chance to enhance your expertise in #DiabetesTechnology through our comprehensive 3-day training programme. 🩺📊
📝Apply now to secure your place👉 www.easd.org/education/me...
#Diabetes #DiabetesCare #Training #Innovation

Interested in #DiabetesTechnology education?

Join the ABCD DTN-UK Educators Day in Manchester for #HCL insights, CGM device standardisation, and emerging evidence of tech use in T2D.

Held on the 25th June at The Studio - register now ow.ly/6Ka950XJxuV

Inter- and intra-physician variability in insulin injection adjustments compared with Bayesian algorithm recommendations in type 1 diabetes - Diabetologia Aims/hypothesis There is an unmet need for automated insulin adjustments for multiple daily injections in type 1 diabetes under unsupervised use. We aimed to assess the McGill decision support system ...

Automated insulin injection adjustments generated by the McGill University #BayesianAlgorithm for adults with #T1D were non-inferior to those made by a group of expert physicians, supporting the algorithm’s use for clinical decision-making. #MDI #DiabetesTechnology link.springer.com/article/10.1...

⏰Just 3 weeks left to apply for the EASD Diabetes Technology School 2026!
This is your chance to advance your skills in current and emerging diabetes technologies.
📅 Deadline: 5 Jan 2026
🔗 👉 www.easd.org/education/me...
#DiabetesTechnology #DiabetesCare #Diabetes

Research from Leicester reveals disparities in access to diabetes technologies, widening inequalities in care for minority ethnic groups.

Read study 🔗 ow.ly/ioyI50X0hvQ

#DiabetesTechnology #HealthInequities

Last chance to join the first of our FREE webinars!

The session, on Thurs 11 Sept, focuses on Continuous Glucose Monitoring (#CGM) for secondary care professionals. Book your place now ⬇️

#HCP #DiabetesEducation #DiabetesTechnology #CPD #SecondaryCare

Dr. Marc Breton’s #ADA2025 talk dropped 🔥 on digital twin models + AID innovations. Neural networks for meal detection & full closed loop = big glycemic gains.
@amdiabetesassn.bsky.social
#ADASciSessions #diabetestechnology

Diabetes technology is evolving rapidly, improving care and quality of life. Working in this field is exciting, and staying on top of advancements is both essential and a privilege. #DiabetesTechnology #MedTech #HealthcareInnovation #DiabetesCare #DigitalHealth

DOM Researcher Spotlight: Michael Hughes, MD | Assistant Professor, Division of Endocrinology, Metabolism, and Lipids - Emory Daily Pulse What is your professional background? I completed my MD and internal medicine residency in Houston at the University of Texas-Houston and Baylor, respectively. I then moved to California for my endocr...

👋 Meet Michael Hughes, MD! After working as an endocrinologist at Stanford, he joins us as faculty in our Division of Endocrinology, Metabolism & Lipids! His research focuses on #DiabetesTechnology, and finding ways to make #InsulinTherapy safer and more effective. 🔗 bit.ly/3WYmu7K

The Latest Advances in Diabetes Technology and Treatments


#diabetes #diabetestechnology #insulinpumps #continuousglucosemonitor #artificialpancreas #smartpens #newmedications #diabetesmanagement #telemedicine #type2diabetes
thediabeticwriter.com/?p=8584

A smartphone screen displaying glucose management data from the Omnipod® 5 system, showing a blood glucose level of 121 mg/dL, along with a white, tubeless insulin pod placed in front of the phone.

Insulet's Omnipod® 5 gets FDA clearance for type 2 diabetes, the first system approved for both type 1 and type 2. It adjusts insulin every five minutes, enhancing HbA1c and glycemic control.

www.omnipod.com

#DiabetesTechnology #InsulinDelivery #Type2Diabetes #Omnipod5 #GlycemicControl